PBS Biotech , an innovative, single-use bioreactor manufacturer and process development services provider, has completed a $22 million financing led by Avego Management, with additional investment from existing investor BroadOak Capital Partners. This financing will be used to improve the company's products portfolio, expand its process development services capability, and increase customer support for global cell therapy clients.